Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this podcast episode, listen to Ursula Matulonis, MD, and Jubilee Brown, MD, discuss new data for gynecological cancers presented at the virtual SGO 2021 meeting, including immunotherapy-based combinations for endometrial cancer and PARP inhibitors for BRCA-mutated ovarian cancers.
This podcast is intended for clinicians practicing medicine outside of the United States.
In this episode, Jubilee Brown, MD, and Ursula Matulonis, MD, provide expert perspectives on new data from SGO 2021 presented for endometrial and ovarian cancer including:
Jubilee Brown, MD
Professor and Director of Gynecologic Oncology
Levine Cancer Institute
Charlotte, North Carolina
Ursula Matulonis, MD
Chief, Division of Gynecologic Oncology
Brock Wilson Family Chair
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Podcast episode with expert insights on important trial data for ovarian and endometrial cancers from the ESGO 2021 annual meeting, from Clinical Care Options (CCO)
Virtual presentation by Angeles Alvarez Secord, MD, MHSc, on individualizing care for women with cervical cancer based on current and emerging clinical data, from Clinical Care Options (CCO)
Virtual presentation by Angeles Alvarez Secord, MD, MHSc, on patient underrepresented and minority women enrollment on clinical trials for cervical cancer, from Clinical Care Options (CCO)
Commentary from Clinical Care Options (CCO): Maria Arcila, MD, discusses recommendations for testing for NRG1 fusions in patients with solid tumors